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CRITICALLY APPRAISED TOPIC 
 
Title:  The efficacy of short wave diathermy in decreasing knee pain in female patients 
with knee osteoarthritis.  
 
Clinical Scenario: A female patient in her mid 80s was admitted to a skilled nursing 
facility due to a non-displaced acetabular fracture following a fall. She was referred to 
physical therapy to address her functional mobility deficits but was having difficulty 
participating in therapy due to increased left knee pain caused by osteoarthritis (OA). 
Diathermy is used throughout the skilled nursing facility, and it was suggested by the 
occupational therapist that I could use this modality to reduce our patient’s knee pain so 
she could better participate in therapy.  
 
Brief introduction: The goal of this paper is to examine whether using diathermy is an 
effective use of the patient’s therapy time and if it would be effective for reducing the 
knee pain caused by OA. Diathermy was first used therapeutically in 1892 and became 
popular in the United States in the 1930’s for its ability to treat infections. It fell out of 
favor in the 1950’s due to the availability of antibiotics, and because of the potential 
hazard to the patient and operator (Cameron, 2009). Currently, use of diathermy in 
clinics is on the rise due to improved technology. It is being used for its thermal effects 
and ability to access a larger/deeper area than ultrasound/hot packs, and for its non-
thermal effects to aid in soft tissue healing (Cameron, 2009). Diathermy uses 
shortwaves of about 1.8 to 30MHz frequency and 3 to 200 meter wavelength to produce 
deep heat and changes within the tissues including vasodilation, elevation of pain 
threshold, increased tissue extensibility and increased enzymatic activity (Cameron, 
2009). To provide non-thermal effects, a low duty cycle is used that allows heat to 
diffuse within the tissues. Proposed non-thermal effects within the tissue include 
modification of ion binding, increased microvascular perfusion and altered cellular 
function and activity. One of the proposed clinical uses of diathermy is for knee 
osteoarthritis (Fukada, 2011). Diathermy is contraindicated if there is a transcutaneous 
neural stimulator, including cardiac pacemaker, or the individual is pregnant. 
Contraindications for thermal level diathermy include metal implants, malignancy, and 
over eyes, testes or growing epiphyses. Non-thermal pulsed diathermy is 
contraindicated over deep tissues such as organs. Possible effects of pulsed shortwave 
diathermy (PSWD) for knee OA include decreasing inflammation and improving ROM, 
pain, stiffness, functional ability, mobility and synovial thickness (Cameron, 2009). 
Diathermy is also proposed as a treatment for edema, nerve healing, bone healing, 
ischemic skin flaps, cerebellar disease, and myocardial disease (Cameron, 2009). 
However, the efficacy of diathermy remains controversial, especially in people with knee 
OA (Fukada, 2011). 
 
My Clinical question: Is diathermy effective for reducing pain for a patient with knee 
osteoarthritis?  
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Clinical Question PICO: 
 
Population – Female, over 65 years old, with knee osteoarthritis 
 
Intervention – Pulsed short wave diathermy applied as a part of physical therapy 
treatment 
 
Comparison – Physical therapy treatment including therapeutic exercise and 
knee functional mobility training  
 
Outcome – Pain as measured by patient reporting on the visual analog scale 
(VAS) 
 
 
Overall Clinical Bottom Line:  
 
There was conflicting evidence between the two articles analyzed. Fukada et al. 
revealed that PSWD used alone, especially low dose as compared to high dose, is 
effective for reducing pain in older adult patients with knee osteoarthritis compared to 
sham PSWD. A number needed to treat (NNT) of 2-3 was determined for PSWD to 
result in one additional person meeting the MCID for pain compared to the control or 
placebo groups. Atamaz et al. did not find a significant difference in pain scores 
between the SWD plus exercise group and a sham SWD plus exercise group. Both 
groups made statistically significant and clinically meaningful changes in pain. Because 
both groups received exercise, it is unknown if similar gains may be made with exercise 
alone, or if the sham SWD had a placebo effect. A comparison group that received 
exercise only would be needed to make this determination. They did, however, find a 
significant decrease in the amount of pain medication used in the SWD group compared 
to the sham group, which may suggest that diathermy is effective for decreasing pain. 
Both studies had strong internal validity, and good methodological quality, but the 
results should be cautiously applied to larger populations due to strict inclusion and 
exclusion criteria. Areas for further research include a study directly comparing an 
exercise control group, a placebo/sham group and a diathermy treatment group to truly 
assess if diathermy is more effective than activity and exercise for reducing pain caused 
by knee osteoarthritis.  
  
Search Terms: Diathermy, pulsed short wave diathermy, skilled nursing facility, older 
adults, pain, knee osteoarthritis, randomized control trial 
 
Appraised By:  Laurel Charbonneau, SPT 
   School of Physical Therapy 
   College of Health Professions 
   Pacific University 
   Hillsboro, OR 97123 
   char9065@pacificu.edu  
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Rationale for your chosen articles 
Medline, CINAHL, Google, Google Scholar, and PubMed were used to find articles to 
answer the clinical question. Search terms that yielded relevant articles included 
diathermy, knee osteoarthritis, and randomized control trial. After finding four articles 
that pertained to the topic, the article PICO was compared to the clinical PICO and the 
studies were examined for methodological quality. The articles listed below closely 
matched the clinical PICO and were found to have relatively high PEDro scores (Table 
1). 
 
Table 1. Comparison of PEDro Scores; taken from pedro.org.au 
 Fukada et al. Atamaz et al. Laufer et al. 
Random Yes Yes No 
Concealed allocation Yes  Yes No 
Baseline comparability Yes Yes Yes 
Blind Subjects Yes Yes Yes 
Blind Therapists No No No 
Blind Assessors Yes Yes Yes 
Adequate Follow-up Yes Yes Yes 
Intention-to-Treat Yes Yes No  
Between Group Yes Yes Yes 
Point Estimates & 
Variability 
Yes Yes Yes 
Total Score 9/10 9/10 6/10 
 
(1) Fukuda TY, Alves da Cunha R, Fukuda VO, Rienzo FA, Cazarini C, Carvalho NAA, 
Centini AA. Pulsed shortwave treatment in women with knee osteoarthritis: a 
multicenter, randomized, placebo-controlled clinical trial. Physical Therapy 2011; 
91(7):1009-1017. 
PEDro Score: 9/10 
Population: 121 women with a mean age of 60 + 9 years old, with a diagnosis of knee 
osteoarthritis 
Intervention: Low dose pulsed shortwave diathermy (PSWD) and high dose PSWD, 
and the advice to stay active 
Comparison: Placebo PSWD treatment and a control group who just received the 
advice to stay active 
Outcome measures: An 11 point numerical pain rating scale and the Knee 
Osteoarthritis Outcome Score (KOOS) measured pretreatment, immediately after the 
three weeks of treatment, and 12 months after treatment 
 
(2) Atamaz FC, Durmaz B, Baydar M, Demircioglu OY, Iyiyapici A, Kuran B, Oncel S, 
Sendur OF. Comparison of the efficacy of transcutaneous electrical stimulation, 
interferential currents, and shortwave diathermy in knee osteoarthritis: a double-blind, 
randomized controlled, multicenter study. Archives of Physical Medicine and 
Rehabilitation 2012; 93(5):748-756. 
PEDro: 9/10 
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Population: Two hundred and three patients aged 50-80 years old with knee 
osteoarthritis 
Intervention: Three groups receiving transcutaneous electrical stimulation (TENS), 
interferential currents (IFC), and shortwave diathermy (SWD)  
Comparison: Sham TENS, IFC and SWD treatment groups, who also received 
exercise and education 
Outcome measures: Visual Analog Scale (0-100mm), time to walk 15m, the Western 
Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Nottingham Health 
Profile, and paracetamol intake in grams, at 1 month, 3 months, and 6 months from 
baseline 
 
(3) Laufer Y, Ziberman R, Poat R, Nahir AM. Effect of pulsed short-wave diathermy on 
pain and function of subjects with osteoarthritis of the knee: a placebo-controlled double 
blind clinical trial. Clinical Rehabilitation 2005; 19:255-263. 
PEDro: 6/10 
Population: One hundred and three patients with mean age of 73.7 + 6 years old, with 
knee osteoarthritis for at least three months. 
Intervention: Pulsed SWD with a mean power of 18W for thermal effect, and 1.8W for 
a-thermal effect. 
Comparison: Sham SWD 
Outcome measures: WOMAC Osteoarthritis Index, Timed Up and Go (TUG), stair 
climbing, stair descending, and a 3-minute walk test, measured at the end of the three 
week treatment and 12 weeks post treatment. 
 
The study by Fukada et al. does not directly compare PSWD to exercise, but examines 
the overall efficacy of the modality for decreasing pain as compared to a placebo and 
control group who were told to maintain their normal activity levels. While the study 
does not match the PICO exactly due to the different comparison groups and a slightly 
younger population, the study has strong methodological quality with a PEDro score of 
9/10 and directly addressed the question of whether PSW diathermy is effective for 
decreasing pain. The study conducted by Atamaz et al. includes a population that is 
also slightly younger than the clinical population and includes other treatment groups 
that do not pertain to the clinical question. However, the study did directly compare 
SWD to exercise, and the outcome measures are very similar to the outcome of 
interest. The study has a high PEDro score , 9/10, representing a stronger study design. 
The study by Laufer et al. had a lower PEDro score, is the oldest date of publication, 
and the article PICO did not closely match the clinical PICO. The comparison group did 
not include exercise or advice to stay active, and the outcome measures did not include 
patient reporting on the VAS or other pain scale. Based on the reasons listed above the 
studies performed by Fukada et al. an Atamaz et al. were selected to answer the clinical 
question in regards to the efficacy of diathermy to decrease knee OA pain.  
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Article: Fukuda TY, Alves da Cunha R, Fukuda VO, Rienzo FA, Cazarini C, Carvalho 
NAA, Centini AA. Pulsed shortwave treatment in women with knee osteoarthritis: a 
multicenter, randomized, placebo-controlled clinical trial. Physical Therapy 2011; 
91(7):1009-1017 
 
Clinical Bottom Line: According to Fukuda et al. there is moderate evidence to 
suggest that both high and low dose pulsed shortwave diathermy, compared to a 
placebo or a control, is an effective way to decrease pain caused by knee OA in adult 
females. Using the NPRS scores, there were statistically significant and clinically 
meaningful decreases in pain scores following 3 weeks (9 sessions) of intervention. 
Seventy five percent of the low dose PSWD group achieved the minimum clinically 
important difference (MCID) of two points on the NPRS scale where as only 15% of the 
placebo group and the control group met the MCID. This results in a number needed to 
treat (NNT) of two people, meaning that two people would need to be treated with low 
dose PSWD to have one additional person meet the MCID.  The high dose PSWD 
group had 50% meet the MCID, resulting in  a number needed to treat of three, 
compared to the placebo or control group. The study had good internal validity. There is 
a relatively low cost to use PSWD if there is already a machine present, and the risk to 
the patient is very low if all contraindications and precautions are followed. The external 
validity was fair, and given the strict inclusion/exclusion criteria the results should 
cautiously be applied to a wider population.  
 
 
Article PICO: 
Population: One hundred twenty-one women with a mean age of 60 + 9 years 
old, with a diagnosis of knee osteoarthritis 
 
Intervention: Low dose pulsed shortwave diathermy (PSWD) or high dose 
PSWD, and the advice to stay active 
 
Comparison: Placebo PSWD treatment and a control group who both received 
the advice to stay active 
 
Outcome measures: An 11 point numerical pain rating scale (0-10), measured 
pretreatment, immediately after the three weeks of treatment, and 12 months after 
treatment 
 
Blinding: The examiner was blinded to group assignment and was responsible for pre-
treatment and post-treatment evaluations. Patients were also blinded, however the 
physical therapists performing the treatment were not blinded.  
 
Controls: There was a true control group of 35 individuals included in this study. They 
did not receive any treatment. There was also a placebo group included. The placebo 
group had the machine positioned but placed in standby mode for 19 minutes. All 
groups included in the study were instructed to remain active. The control group had 
 6
less contact time with therapists and researches in the study as compared to the 
placebo and two treatment groups. Otherwise the groups were treated similarly.  
 
Randomization: The 121 participants were randomly assigned to one of the four 
treatment groups. Assignment was concealed using sealed opaque envelopes and an 
individual who was not involved in the study assigned participants a group. 
Randomization was successful as there were no differences between the groups at 
baseline (p>0.05). 
 
Study: The authors of the article utilized a prospective, randomized, placebo-controlled, 
multicenter study design. The study took place at University of Sao Paulo Medical 
School in Brazil between August of 2006 and December of 2008. One hundred twenty-
one women met the inclusion criteria of being over 40 years old, having primary grade II 
or III knee OA based on Gupta and colleagues’ radiographic criteria, and had joint or 
anterior knee pain for at least three months. Participants were excluded if they had knee 
surgery or any other invasive procedure that affected the knee, physical therapy for 
knee injuries, any medication that had changed within the last 3 months, any other 
diseases affecting function, or patients who presented with any of the contraindications 
for PSWD treatment including metallic implants, pacemakers, lack of sensitivity or a 
tumor.    
 The 121 participants were randomized into four groups with 35 people in the 
control group receiving no treatment, 23 in the placebo group, 32 in the low dose PSWD 
group and 31 in the high dose PSWD group. The treatment groups received three 
applications of PSWD per week, for three weeks, for a total of 9 sessions. The low 
PSWD group received the treatment for 19 minutes with approximately 17 kJ of energy 
each session, whereas the high PSW group received 38 minutes of treatment with a 
total of 33 kJ of energy. The pulse frequency was 145 Hz, with the mean power of 
14.5W. The machines used in the study were previously calibrated Diathermed II 
machines. One electrode was placed on the anterior area of the thigh 5 cm above the 
superior border of the patella and the second electrode was applied on the posterior 
area of the leg. The participant was positioned in supine for the treatment, with the knee 
in 20 degrees of flexion and the physical therapists did not remain with the participants 
to avoid influencing the results. All the participants received the advice to maintain their 
daily activities and to avoid anti-inflammatory drugs.  
 
Outcome measures: The participants were analyzed using an 11-point numerical pain 
rating scale (NPRS) with 0 corresponding to “no pain” and 10 corresponding to “worst 
imaginable pain.” The participants were analyzed pre-treatment, immediately post-
treatment after the 3 weeks, and again at 12-month follow up. According to the authors 
the NPRS has been shown to be reliable and valid, and has a MCID of 2 points.  
 
Study losses: The control group initially had 35 individuals, and after the three weeks of 
treatment three were lost representing a 9% loss. The control group did not take part in 
the 12-month follow up because after the treatment period they were referred for 
traditional physical therapy treatment. The placebo group started with 23 individuals and 
lost two people after the three weeks of treatment, representing a 9% loss. An additional 
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seven individuals were lost at the 12-month follow up representing an additional 33% 
loss. The low-dose PSWD group began with 32 individuals; two were lost following 
treatment, a 6% loss, and an additional 11 people were lost at the 12-month follow up 
evaluation, a 37% loss. The high-dose PSWD group lost two individuals initially post-
treatment, representing a 6% loss, and an additional 11 people at the 12-month follow 
up representing a 38% loss. Individuals that were lost within the three weeks of 
treatment were due to missing two or more treatment sessions. The reasons that people 
dropped out the study by the 12-month follow up included seeking out other treatment, 
having a total knee replacement, or not able to be contacted.   
From the pretreatment to the initial post-treatment analysis nine participants 
dropped out of the study. According to the authors an intention to treat analysis was not 
needed because this represents less than a 10% loss and did not compromise the 
effect size of interest. According to the authors the sample size calculations were 
conducted to detect an 8-point difference on the KOOS scale, which was not of interest 
to this paper, and 20% difference between groups, assuming 13 point standard 
deviation, two tailed distribution, with 80% power, and an alpha value of 0.05. The 
specific number of participants that was calculated to be needed was not included in the 
article. A total of 29 participants out of the 112 were lost from the initial post-treatment 
analysis to the 12-month follow up so an intention to treat analysis was necessary. The 
authors carried forward the last known value to conduct the intention to treat analysis.  
 
 
Summary of internal validity: The study has good internal validity. Randomization was 
successful as there were no statistically significant differences between the groups at 
baseline for demographic information or for the outcome measures. The authors utilized 
a strict protocol, and all the participants were evaluated within the groups to which they 
were randomized. The participants and evaluators were blinded to the treatment and 
the study utilized both a true control and a placebo group. One minor threat is that there 
was no intention to treat analysis performed for the data collected initially post-
treatment. Even though the authors state that the intention to treat analysis was not 
needed, because the losses did not impact the effect size of interest, the losses still 
represented 6-9% of the participants. Also the reasons for the losses were not included 
for this time period; therefore, people may have missed appointments because they felt 
the treatment was not helping, they felt much better, etc. Another minor threat is that the 
physical therapists were not blinded because they had to perform the treatment. This 
threat was minimized by not allowing the physical therapists to remain with the 
participant, but there is still a threat of the therapist influencing the participant. Another 
minor threat to validity is that the control group was not measured at the 12-month 
follow up, meaning it is unknown if the improvements were seen due to time, but 
knowing the typical progression of OA, and also having a placebo group that was 
measured at all time points lessens the threat.  
 
Evidence: The post-treatment analysis for low-dose PSWD group showed a significant 
improvement in pain scores on the NPRS as compared to the pretreatment score, 
p<0.001 (Table 3). The posttreatment analysis for high-dose PSWD group also showed 
a significant improvement, p<0.01 (Table 3). The amount of change the low and high-
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dose PSWD groups made at the post-treatment evaluation met the MCID of two points, 
with values of 3.3, and 2.1 respectively (Table 2). There was no significant decrease in 
pain within the control group or placebo group.   
 
 
Table 2: Numerical Pain Rating Scale Values + SD, at pretreatment, post-treatment, 
and at 12-month follow up.  
Group Time point 1: 
Pretreatment 
Time Point 2: 
Posttreatment 
Time Point 3: 12-
Month Follow up 
Mean difference 
(95%CI): Time 
Point 1 to 2, and 1 
to 3 
Control 6.1+2.1 (n=35)  5.6+ 2.1 (n=32)  NA 0.5 (-.59-1.59), NA 
Placebo  7.7+ 1.4 (n=23) 6.9 + 2.0 (n=21) 7.5+1.6 (n=14) 0.8 (-.30-1.90),       
-0.2 (-0.83-1.23) 
Low-dose 
PSW 
7.1+2.8 (n=32) 3.8+2.2 (n=30) 5.7+3.0 (n=19) 3.3*(2.31-4.29),  
-1.4 (0.15-2.65) 
High-dose 
PSW 
 6.7+2.5 (n=31) 4.6+3.5 (n=29) 5.2+2.1 (n=18) 2.1*(0.44-3.76),      
-1.5(0.07-2.93) 
A (–) represents a decrease in pain score. *=clinically and statistically significant data. 
 
Seventy-five percent of the low dose group and 50% of the high dose PSWD group met 
the MCID of two points and only 15% of the of the placebo group and 15% of the control 
group met the MCID. From this data, I calculated the number needed to treat to be two 
people for the low dose and three people for the high dose PSWD groups. This means 
that two people would need to be treated with low dose or three people treated with high 
dose PSWD to have one additional person meet the MCID for pain compared to the 
control or placebo groups.  
 
There was a large effect size for the low-dose PSWD group (1.18) and the high-dose 
PSWD group (0.84) at the initial posttreatment evaluation (Table 3). At the 12 month 
follow-up there was a medium effect size for low-dose PSWD group (0.5) and high-dose 
PSWD group (0.60) (Table 3). The 95% percent confidence intervals included a wide 
range. The low end of the effect size for the low dose post-treatment was still large. The 
effect size for the high-dose at the post-treatment analysis was small. If the study were 
repeated the low dose diathermy would still have a large effect, but the high dose may 
only have a small effect. At 12 months post intervention the low end of the confidence 
interval crosses zero, meaning that if the study were to be repeated there may be no 
effect or possible a worsening effect (Table 3). 
 
 
 
 
Table 3: Within group effect size scores with 95% Confidence Intervals (CI) for NPRS 
scores for the Control group, Placebo group, Low-Dose PSWD group, High-Dose 
PSWD group 
Group  Effect size for pre P values for Effect size from P values for 
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to post-treatment pre to post-
treatment 
pretreatment to 
12-month follow-
up 
pretreatment 
to 12-month 
follow-up 
Control NA p>0.05 NA NA 
Placebo NA p>0.05 0.14 (-0.53-0.80) p>0.05 
Low-dose PSW 1.18 (0.76-1.85) p<0.001 0.50 (-.09-1.06) p<0.05 
High-dose PSW 0.84  (0.17-1.22) p<0.01 0.60 (-.04-1.23) p<0.05 
Effect size and CI are calculated data, p values are taken from the article 
 
 
The between group comparison showed a significant improvement for the low-dose 
PSWD group compared to the placebo and control groups, p<0.05 and p<0.01 
respectively, for the post-treatment analysis but there was no difference between 
groups at the 12 month follow up (Table 4). There was no difference between the high 
dose PSWD group and the placebo or control group at either time point.  
 
 
Table 4: Between group comparison of NRPS at post-treatment evaluation. 
Intervention NRPS 
score  
Comparison NRPS 
Score 
P value Effect size (95% CI) 
Low-dose PSW: 
3.8+2.2 (n=30) 
Placebo: 6.9+2.0 
(n=21) 
p<0.05 1.46  (0.84-2.09) 
Low-dose PSW: 
3.8+2.2 (n=30) 
Control: 5.1+2.1 
(n=32) 
p<0.01 0.60 (0.03-1.17) 
 
Benefits vs. Costs: There would be a significant financial cost if the clinic did not already 
own a diathermy machine. According P and P Cito the cost of the Diathermed II, the 
machine used in the study was $4,600 and there would be additional costs to have the 
machine calibrated and serviced (http://www.en.ppcito.com). If the previously mentioned 
precautions and contraindications are followed then there is little risk to the patient. One 
possible adverse effect of diathermy, however, is burns. Fat layers are at the greatest 
risk, and because water is preferentially heated, sweat may scald the skin. Therefore a 
dry towel placed over the skin is recommended to prevent such an occurrence 
(Cameron, 2009). The authors reported that use of PSWD resulted in no adverse 
events during the study. Overall, the study demonstrated that the treatment is effective 
for a meaningful decrease in pain in participants with knee OA. The treatment did not 
cost an inordinate amount of the patient’s or therapist’s time. Therefore, if the clinic 
already has access to a diathermy machine and caution is taken to avoid 
contraindications and precautions the benefits outweigh the costs. Additionally, results 
show that there is a greater positive effect using low-dose as compared to high dose 
diathermy. Therefore using low-dose diathermy has the greatest benefit for pain caused 
by knee OA.   
Feasibility of treatment: The time and duration for the treatment is a reasonable amount 
that would be allowed by insurance. The procedure was well described so it is 
repeatable. As long as a clinic already had this device there is minimal additional 
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requirements for clinical expertise or time needed to provide the treatment, as long as 
the therapist has basic knowledge for using the machine. A correctly applied treatment 
should not cause discomfort and there were no pain/burns from treatment reported in 
the study. Additionally, the success of the treatment did not rely on patient participation. 
Overall the treatment protocol is feasible.  
 
Summary of external validity: Overall the study has fair external validity. The population 
was slightly younger than the clinical population. The inclusion criteria were strict, so it 
may be difficult to generalize the results. For instance, participants were not included if 
they had received physical therapy previously, had any invasive knee procedures or if 
they had grade I OA. So it is unknown if the results can be extrapolated to individuals 
beyond their inclusion criteria. Additionally, the study also took place in Brazil so there 
may be some cultural difference that could impact the outcomes. Overall, because of 
the good internal validity and similarity to the clinical population the results can be 
extrapolated to a subset the clinical population that overlaps with the inclusion criteria.   
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Article: Atamaz FC, Durmaz B, Baydar M, Demircioglu OY, Iyiyapici A, Kuran B, Oncel 
S, Sendur OF. Comparison of the efficacy of transcutaneous electrical stimulation, 
interferential currents, and shortwave diathermy in knee osteoarthritis: a double-blind, 
randomized controlled, multicenter study. Archives of Physical Medicine and 
Rehabilitation 2012; 93(5): 748-756. 
 
 
Clinical Bottom Line: According to Atamaz et al. there is moderate evidence to 
suggest no significant difference in patient reported pain scores on the visual analog 
scale comparing SWD plus exercise/education to sham SWD plus exercise/education. 
Both groups made statistically significant and clinically meaningful decreases in pain. 
There was a significant decrease in the amount of the oral analgesic taken by the group 
that received SWD as compared to the group that received the sham SWD at the three-
month assessment p<0.05. Overall, the study had good internal validity and fair external 
validity. Due to the high level of exclusion criteria, these outcomes should be cautiously 
generalized to larger populations. 
 
Article PICO: 
 
Population: Two hundred and three patients aged 50-80 years old with knee 
osteoarthritis 
 
Intervention: Shortwave diathermy (SWD) treatment given five times a week in 
addition to exercise and education 
 
Comparison: Sham SWD treatment given 5 times a week and also received 
exercise and education  
 
Outcome measures: Visual Analog Scale (VAS), 0-100mm measured at 
baseline, one month, three months, and six months.  
 
 
Blinding: The patients, investigators and analysts were all blinded. The data and safety 
monitoring board members were not blinded but they did not participate in the 
assessment of patients or in writing the paper. The therapists were also not blinded.  
 
Controls: There was a SWD sham group, which received the same education, exercise 
and instruction as the treatment group and were seen for the same frequency and 
duration as the treatment group but were set up with a sham treatment.  
 
Randomization: Patients were assigned a unique two-part number and were randomly 
allocated to one of the six treatment groups. Randomization was successful as there 
were no significant differences between groups at baseline.  
 
Study: The design was a double blind multicenter, randomized controlled study. The 
sample size was calculated at 28 individuals per group with 80% power to detect a 50% 
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improvement in VAS scores with a two-sided significance level (p<0.05) with a 30% 
dropout rate. Participants 50-80 years old were included in the study and had to have 
OA with a Kellgren-Lawerence grade of two or three with radiographical confirmation. 
To be included in the study the participants had to have rated their pain at 40mm or 
greater on the VAS. Patients were excluded if they had previous experience with 
electrical stimulation, if treatment was contraindicated, if they had a corticosteroid or 
chondro-protective agent within the last 30 days, had viscosupplementation treatment 
within the last six months, or had a surgery such as a joint replacement or arthroscopy 
within in six months of the study. Patients were also excluded if they were pregnant, 
breast feeding, had joint infection, were diagnosed with a specific condition such as 
neoplasm, diabetes mellitus, paresis, osteonecrosis, recent trauma, etc., or poor 
general health that would interfere with the participants ability to complete the functional 
assessments.  
 Six groups in total were included but only the SWD group and sham SWD group 
will be analyzed to address the clinical question. The average age in the SWD group 
was 61.6 + 7.4 years, and the average age of the sham SWD group was 61.4+8.2 years 
old. The physical therapists were trained to apply the treatments in a standardized way. 
All treatments were applied five times a week for three weeks. The SWD groups had a 
screen placed in front of them so they could not see the machine. The patient placed his 
or her leg on a table and received continuous diathermy with a 10 cm condenser plate 
at a frequency of 27.12MHz at 300W input and a 3.2W output for a total of 20 minutes. 
The sham group was positioned the exact same way except the power switch was off.  
 All the groups received therapeutic exercise and education. The exercise was 
completed in groups of four to five participants three times a week for three weeks. 
First, the participants jogged for five to six minutes, and then completed 10 minutes of 
stretching of lower extremity muscles in a standing position. Following the warm up, 10-
15 sets of isometric quadriceps contractions of 10 second holds in long sitting/supine 
with a rolled towel under the knee, chair lifts, and mini squats were performed. 
Following the three weeks of interventions the participants were instructed to maintain 
the exercises at home. Everyone received pre-made exercise cards with instructions. All 
the participants also received a one-hour education class about knee OA, the 
progression, the function of the knee, joint protection, ergonomics, exercise and 
treatment approaches from a computer lesson given by the physician.  
 
Outcome measures:  The participants were assessed at baseline, one, three and six 
months post treatment utilizing a 100mm VAS to assess the patient’s knee pain, with 0 
equating to no pain, and 100 equating to severe pain. The authors did not include 
information about the validity, reliability or MCID for the pain VAS for patients with knee 
OA. According Tubach et al. a minimal clinically important improvement (MCII) for 
patients with knee OA is -19.9mm on the VAS (2005). 
 
Study losses: The authors state that an intention to treat analysis was performed, but 
did not specify the method utilized. Two-hundred and three patients were included in the 
study. Of the treatment groups of interest 31 were in the SWD group and 32 were in the 
sham SWD group at the beginning of the trial. For the SWD group, no one dropped out 
at one month, three dropped out at three months, and one dropped out at six months. 
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Reasons for leaving the study include worsening of symptom (n=2), and health 
problems not related to knee pain, (n=2). For the sham SWD group two people dropped 
out at one month, one dropped out at three months, and four dropped out at six months. 
The reasons for leaving the study include worsening symptoms (n=5), and not enough 
time to attend (n=2).  Twenty-five people out of 32 people completed the study in the 
SWD sham group which represents a 22% loss. Twenty-seven out of 31 people 
completed the study in the SWD group which represents a 12% loss.  
 
Summary of internal validity: The study has good internal validity. There was blinding 
of subjects, assessors and investigators. There was an intention to treat analysis used, 
and successful randomization of subjects with all groups equal at baseline. There were 
three minor threats. One of the threats was not reporting how intention-to-treat analysis 
was conducted. Some of the participants dropped out of the study because of 
worsening conditions and the author do not state how they analyzed those values. 
Therapists were not blinded in the study, which could have affected the participants’ 
perception of treatments, their condition, etc. Another minor risk to internal validity that 
was noted by the authors was the difficulty of blinding patients to the particular 
treatment. This is due to the sensory component associated with modality, but not felt 
with the sham. They tried to minimize this risk by selecting participants that had never 
received the treatment before.  
 
Evidence: The results were analyzed using a paired t-test to compare the treatment 
group to the sham treatment. There was no significant difference in pain VAS scores 
between the SWD treatment and SWD sham group at any of the assessment points, but 
both the sham and the treatment group showed significant improvement from baseline 
(p<0.05). The authors did not include an MCID but if the MCII established by Tubach et 
al. of -19.9mm is used then the values at each point exceed the MCII. (Table 5) 
 
Table 5: Mean difference on VAS scores from baseline VAS scores.  
Mean 
difference  
1 month 3 months 6 months 
SWD sham -26mm -29.8mm -29.2mm 
SWD -28.7mm -30mm -25.7mm 
 
 
While it was not the primary outcome measure of interest, the study did show that the 
SWD group used less of the analgesic, paracetamol (acetaminophen), than the sham 
group during the first three months, p<0.05. The exact values, however, were not 
included so effect size and confidence intervals cannot be calculated.  
 
Benefits vs. Costs:  A benefit of using SWD may be decreased intake of the analgesic 
medication, as compared to the sham SWD group. Both the SWD and the sham SWD 
were combined with an exercise program and resulted in a clinically meaningful 
decrease in pain. No difference in the overall pain reported on the VAS was found 
between the groups. It is unknown if the similarity between groups is due to a placebo 
effect from the sham diathermy, or if the SWD had no impact and the improvements 
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were from the exercises that both groups received. There was no group that received 
exercise only, so this cannot be determined. Costs of the treatment include the cost to 
purchase and maintain the machine and cost to the patient to attend therapy. There is a 
slight risk of burns to the patient, but if the therapist is in compliance with the 
indications, contraindications and precautions, there is overall low risk to the patient 
(Cameron, 2009). Overall, the time and cost needed for treatment and the expense of 
purchasing the needed equipment is greater than the benefits received from the 
treatment.  
 
Feasibility of treatment: The treatment was performed five times per week, which is 
more than a typical out-patient treatment would include but is similar for an inpatient 
population, which matches the clinical population. The exercise included a warm up of 
jogging for five to six minutes. While this was perhaps a mistranslation, I find it hard to 
believe that people with knee OA with a starting pain score of 40mm were appropriate 
to jog as a warm up. I do feel that jogging may not be feasible for the clinical population. 
Overall SWD treatment itself is a feasible treatment in that it does not take too much 
time, effort, or include harm for the patient.  
 
Summary of external validity: The article population was similar to the clinical 
population. There were some differences as the age range included subjects that were 
younger and they included males and females.  Additionally the study took place in 
Turkey, so there may be cultural difference that would affect the application of the 
results to the clinical population. Overall the article PICO matched the clinical PICO 
relatively well so the results can be applied to a subset of the clinical population. There 
were very strict exclusion criteria to participate in the study such as individuals with 
diabetes mellitus, knee arthroscopy, etc. so I cannot confidently determine if the results 
can be applied to a larger population.  
 
 
 
Synthesis/Discussion 
 
The purpose of this paper was to determine if SWD was effective in reducing pain in 
people with knee OA. There was a discrepancy in the findings of the two studies 
reviewed. Fukada et al. found a significant decrease in pain scores in the PSWD 
treatment group compared to a placebo and a control group. Atamaz et al. did not find a 
significant change in pain scores in the SWD group as compared to a sham SWD 
group. They did, however, find a significant decrease in the use of pain medication in 
the SWD group compared to the sham group at the three-month follow-up. Both studies 
had equivocal internal validity (PEDro scores of 9/10), so evidence for one study will not 
be weighted higher than the other.  
 
The populations used within both studies were slightly younger than the population in 
question of individuals 65 years and older. The average age range in Fukada et al. was 
60 years old including people as young as 40 years old, and the average in the study by 
Atamaz et al. was 61 years old with people as young as 50 years old. Additionally 
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Atamaz et al. included males and females in the study. Being that populations within the 
two studies were very similar I do not believe that this contributed to the varying results. 
Since the age averages were 60 and 61 years old, and the population in question was 
patients 65 years and older, I am more cautious to apply the result to older populations.  
 
The treatments used did not appear to be markedly different. Both studies utilize a 
standardized diathermy treatment for a similar duration of three weeks, and had a 
similar amount of participants per group. Some differences, however, did exist. 
There were different treatment parameters used. The treatment group in Atamaz’s et al. 
study received continuous diathermy five days a week for three weeks for a total of 15 
sessions, whereas the group in the study by Fukada et al. received continuous 
diathermy three sessions per week for three weeks for a total on nine sessions. The 
difference between treatment groups (pulsed vs. continuous diathermy) may have 
contributed to the difference seen in the results of the two studies.  
 
The comparison groups were different between studies. Fukuda et al. had a sham 
PSWD group and a true control group, so efficacy of the PSWD could be isolated. With 
Atamaz et al., however, both groups received exercise and education, so the effects of 
SWD alone could not be determined. Only its benefits combined with exercise could be 
determined. So it is unknown if there was no significant difference between groups 
because of the placebo effect of the sham diathermy, or because the exercise was what 
was effective for reducing pain. The difference in the comparison groups may have 
directly impacted the results of the study. The group that included exercise in the 
treatment and comparison group found no significant difference, whereas the group that 
had a true sham, control and treatment group did find a significant difference. This could 
suggest that if diathermy could have been isolated a difference between the groups may 
have been seen in the second study as well. 
 
Recommendations for future research include the efficacy of pulsed diathermy 
compared to continuous diathermy treatment for knee osteoarthritis pain in older adults. 
Additionally, areas for further research may include a study directly comparing an 
exercise control group, a placebo/sham group and a diathermy treatment group to truly 
assess if diathermy is more effective than exercise for reducing pain caused by knee 
osteoarthritis.  
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